| Code | CSB-RA011593MB4HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to TEV-53408, specifically designed to target interleukin-15 (IL-15), a pleiotropic cytokine that plays critical roles in immune cell development, activation, and homeostasis. IL-15 is essential for the proliferation and survival of natural killer cells, CD8+ memory T cells, and other lymphocyte populations. It signals through a heterotrimeric receptor complex and shares functional similarities with IL-2, though with distinct physiological roles. Dysregulated IL-15 expression has been implicated in various autoimmune disorders including rheumatoid arthritis, inflammatory bowel disease, and psoriasis, as well as in certain hematological malignancies and transplant rejection.
TEV-53408 represents a therapeutic antibody developed to neutralize IL-15 activity and has been investigated in clinical settings for immune-mediated conditions. This biosimilar provides researchers with a valuable tool for investigating IL-15-mediated signaling pathways, studying immune cell biology, and exploring potential therapeutic interventions in diseases characterized by aberrant IL-15 activity. The antibody enables detailed mechanistic studies of cytokine networks and immune regulation in various experimental models.
There are currently no reviews for this product.